Is a complete IKT research report available?

No complete published report is available for Inhibikase Therapeutics, Inc. (IKT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Inhibikase Therapeutics, Inc. (IKT)

NASDAQ: IKT · USD

$1.60

+0.03 (+1.9%)· Recorded snapshot

Market cap	291.3M
Net income (ttm)	-60.6M
EPS (ttm)	-$0.43
Shares out	182.1M
Volume	305,884
Beta	0.90

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -60.6M
EPS (ttm): -$0.43
Market cap: 291.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Conserver

Metric	Value
Amount currency	USD
CIK code	0001750149
Company name	Inhibikase Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	45719W205
Earnings date	2026-11-13
Earnings time	amc
Employees	35
Employees change	19
Employees growth	118.75%
Enterprise value	$132.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2008
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2020-12-23
Is primary listing	Yes
Is SPAC	No
ISIN number	US45719W2052
Last 10-K release date	2026-03-26
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split date	2023-06-30
Last stock split type	Reverse
Market cap	$291.3M
Market cap category	Micro-Cap
Next earnings date	2026-11-13
Options	No
Price	$1.60
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	IKT
U.S. state	Delaware
Website	https://www.inhibikase.com

Metric

Value

Amount currency

USD

CIK code

0001750149

Company name

Inhibikase Therapeutics, Inc.

Country

United States

Country code

CUSIP number

45719W205

Earnings date

2026-11-13

Earnings time

amc

Employees

Employees change

Employees growth

118.75%

Enterprise value

$132.3M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2008

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2020-12-23

Is primary listing

Yes

Is SPAC

ISIN number

US45719W2052

Last 10-K release date

2026-03-26

Last earnings date

2026-08-11

Last refreshed

2026-10-28

Last stock split date

2023-06-30

Last stock split type

Reverse

Market cap

$291.3M

Market cap category

Micro-Cap

Next earnings date

2026-11-13

Options

Price

$1.60

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

IKT

U.S. state

Delaware

Website

https://www.inhibikase.com

Metric	Value
Earnings yield	-27.04%
FCF / EV yield	-33.6%
FCF yield	-14.91%
Forward EV/Sales	676.47x
Forward P/S	1,524.57x
P/B ratio	1.79x
Price / tangible book value	1.86x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Earnings yield

-27.04%

FCF / EV yield

-33.6%

FCF yield

-14.91%

Forward EV/Sales

676.47x

Forward P/S

1,524.57x

P/B ratio

1.79x

Price / tangible book value

1.86x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
Profit per employee	$-1.7M
ROA	-32.79%
ROA (5Y)	-36.33%
ROCE	-43.19%
ROE	-51.96%
ROE (5Y)	-65.8%
ROIC	-35.46%

Metric

Value

Profit per employee

$-1.7M

ROA

-32.79%

ROA (5Y)

-36.33%

ROCE

-43.19%

ROE

-51.96%

ROE (5Y)

-65.8%

ROIC

-35.46%

Metric	Value
EPS growth years	4
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$0
Depreciation and amortization	$53,937
EBIT	$-66.2M
EBITDA	$-66.2M
EPS	$-0.43
FCF per share	$-0.23
Financing cash flow	$111.3M
Free cash flow	$-42.6M
Free cash flow minus SBC	$-62.6M
Investing cash flow	$-115.2M
Net cash flow	$-46.5M
Net income	$-60.6M
Operating cash flow minus SBC	$-62.6M
Operating income	$-66.2M
Stock-based compensation	$20M

Metric

Value

Capital expenditures

Depreciation and amortization

$53,937

EBIT

$-66.2M

EBITDA

$-66.2M

EPS

$-0.43

FCF per share

$-0.23

Financing cash flow

$111.3M

Free cash flow

$-42.6M

Free cash flow minus SBC

$-62.6M

Investing cash flow

$-115.2M

Net cash flow

$-46.5M

Net income

$-60.6M

Operating cash flow minus SBC

$-62.6M

Operating income

$-66.2M

Stock-based compensation

$20M

Metric	Value
Book value per share	$0.88
Debt / equity	0
Long-term assets	$1.2M
Long-term liabilities	$0
Net cash (debt)	$159M
Net cash / market cap	55.63%
Net cash growth	81.47%
Net debt / equity	-1.04
Piotroski F-Score	2
Shareholders' equity	$153.3M
Tangible book value	$153.3M
Tangible book value per share	$0.88
Total assets	$163.6M
Total cash	$159M
Total debt	$0
Total liabilities	$10.3M
WACC	9.19%

Metric

Value

Book value per share

$0.88

Debt / equity

Long-term assets

$1.2M

Long-term liabilities

Net cash (debt)

$159M

Net cash / market cap

55.63%

Net cash growth

81.47%

Net debt / equity

-1.04

Piotroski F-Score

Shareholders' equity

$153.3M

Tangible book value

$153.3M

Tangible book value per share

$0.88

Total assets

$163.6M

Total cash

$159M

Total debt

Total liabilities

$10.3M

WACC

9.19%

Metric	Value
Current assets	$162.3M
Current liabilities	$10.3M
Current ratio	15.82
Net working capital	$-6.9M
Quick ratio	15.5
Working capital	$152.1M

Metric

Value

Current assets

$162.3M

Current liabilities

$10.3M

Current ratio

15.82

Net working capital

$-6.9M

Quick ratio

15.5

Working capital

$152.1M

Metric	Value
Buyback yield / dilution	-115.18%
Dividend yield	0%
Shareholder yield	-115.18%

Metric

Value

Buyback yield / dilution

-115.18%

Dividend yield

Shareholder yield

-115.18%

Metric	Value
150-day SMA	$1.99
1D price change	1.91%
1M price change	-22.82%
1M total return	-22.82%
1W price change	-7.02%
1W total return	-7.02%
1Y price change	1.92%
1Y return CAGR	1.92%
1Y total return	1.92%
20-day SMA	$1.78
200-day SMA	$1.94
3M price change	-32.34%
3M total return	-32.34%
3Y price change	91.01%
3Y return CAGR	24.07%
3Y total return	91.03%
50-day SMA	$2.11
50-day SMA vs 200-day SMA	50over200
52-week high	$2.61
52-week high date	2026-09-03
52-week low	$1.33
52-week low date	2025-11-03
5Y price change	-86.68%
5Y return CAGR	-33.19%
5Y total return	-86.68%
6M price change	-15.87%
6M total return	-15.87%
All-time high	$70.80
All-time high date	2020-12-23
All-time low	$0.79
All-time low date	2023-10-10
Average true range (ATR)	$0.11
Average volume	660.2K
Beta (1Y)	1.34
Beta (2Y)	1.84
Beta (5Y)	0.9
Change from 52-week high	-38.7%
Change from 52-week low	20.3%
Change from all-time high	-97.75%
Change from all-time low	101.27%
Change from open	4.23%
Day's gap	-2.23%
Dollar volume	$489,414
High price	$1.61
Low price	$1.54
Monthly RSI	39.68
Open price	$1.54
Position in 52-week range	92.86%
Previous close	$1.57
Price vs 150-day SMA	-20.14%
Price vs 20-day SMA	-10.52%
Price vs 200-day SMA	-17.91%
Price vs 50-day SMA	-24.54%
Relative volume	0.46
Return from IPO open	-97.55%
Return from IPO price	-84.3%
RSI	32.24
Sharpe ratio	0.28
Sharpe ratio (3Y)	0.64
Sharpe ratio (5Y)	0.02
Sortino ratio	0.53
Sortino ratio (3Y)	1.11
Sortino ratio (5Y)	0.09
Volume	305.9K
Weekly RSI	36.85
YTD price change	-22.44%
YTD total return	-22.44%

Metric

Value

150-day SMA

$1.99

1D price change

1.91%

1M price change

-22.82%

1M total return

-22.82%

1W price change

-7.02%

1W total return

-7.02%

1Y price change

1.92%

1Y return CAGR

1.92%

1Y total return

1.92%

20-day SMA

$1.78

200-day SMA

$1.94

3M price change

-32.34%

3M total return

-32.34%

3Y price change

91.01%

3Y return CAGR

24.07%

3Y total return

91.03%

50-day SMA

$2.11

50-day SMA vs 200-day SMA

50over200

52-week high

$2.61

52-week high date

2026-09-03

52-week low

$1.33

52-week low date

2025-11-03

5Y price change

-86.68%

5Y return CAGR

-33.19%

5Y total return

-86.68%

6M price change

-15.87%

6M total return

-15.87%

All-time high

$70.80

All-time high date

2020-12-23

All-time low

$0.79

All-time low date

2023-10-10

Average true range (ATR)

$0.11

Average volume

660.2K

Beta (1Y)

1.34

Beta (2Y)

1.84

Beta (5Y)

0.9

Change from 52-week high

-38.7%

Change from 52-week low

20.3%

Change from all-time high

-97.75%

Change from all-time low

101.27%

Change from open

4.23%

Day's gap

-2.23%

Dollar volume

$489,414

High price

$1.61

Low price

$1.54

Monthly RSI

39.68

Open price

$1.54

Position in 52-week range

92.86%

Previous close

$1.57

Price vs 150-day SMA

-20.14%

Price vs 20-day SMA

-10.52%

Price vs 200-day SMA

-17.91%

Price vs 50-day SMA

-24.54%

Relative volume

0.46

Return from IPO open

-97.55%

Return from IPO price

-84.3%

RSI

32.24

Sharpe ratio

0.28

Sharpe ratio (3Y)

0.64

Sharpe ratio (5Y)

0.02

Sortino ratio

0.53

Sortino ratio (3Y)

1.11

Sortino ratio (5Y)

0.09

Volume

305.9K

Weekly RSI

36.85

YTD price change

-22.44%

YTD total return

-22.44%

Metric	Value
Float	107.1M
Float percentage	58.84%
Shares change (QoQ)	1.31%
Shares change (YoY)	115.18%
Shares held by insiders	1.46%
Shares held by institutions	66.41%
Shares outstanding	182.1M
Short % of float	18.14%
Short % of shares	10.67%
Short ratio	34.8 days

Metric

Value

Float

107.1M

Float percentage

58.84%

Shares change (QoQ)

1.31%

Shares change (YoY)

115.18%

Shares held by insiders

1.46%

Shares held by institutions

66.41%

Shares outstanding

182.1M

Short % of float

18.14%

Short % of shares

10.67%

Short ratio

34.8 days

Inhibikase Therapeutics, Inc. (IKT)

Price

Financial snapshot

Fair-value bridge

Latest news · IKT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IKT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on IKT

Frequently asked questions